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Abstract
Background: Patients with chest pain or palpitations often have poor outcomes following a negative cardiac
evaluation, with symptom persistence, limitations in everyday activities, and reduced health-related quality of life.
The aims of this study were to evaluate illness perceptions before and after negative cardiac evaluations and
measure the ability of a self-report questionnaire to predict outcomes.
Methods: Patients (N= 138) referred for chest pain or palpitations to a cardiac outpatient clinic were assessed
before and six months after a negative cardiac evaluation. In addition to Brief Illness Perception Questionnaire
(BIPQ), all patients completed the Beck Depression Inventory and SF-36 Health Survey.
Results: The emotional reactions to and understanding of symptoms had not improved six months after a negative
cardiac evaluation. A stronger correlation between illness perceptions and health at follow-up than before the
cardiac evaluation might explain the tendency for poor outcomes among these patients. Most of the eight BIPQ
item scores before the negative cardiac evaluation were predictive of the outcome six months later. A single
question asking about the perceived consequences of the complaints (BIPQ Item 1) rated before the cardiac
evaluation was collapsed into a dichotomous variable with a cut-off at ≥4 which yields a sensitivity of 51%, a
specificity of 85%, a positive predictive value of 71%, a negative predictive value of 69%, and an odds ratio of 5.7
(r= .38, p < .001) in predicting poor outcomes.
Conclusions: Assessing illness perceptions is important in patients with negative cardiac tests for understanding
and predicting outcomes.
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Background
Chest pain and palpitations are the two most common
reasons for referral to a cardiologist [1]. Most of these
patients suffer from non-cardiac chest pain and benign
palpitations [2-4]. Little is known about the course of
psychological symptoms from before to after negative
cardiac evaluation. However, studies which have evalu-
ated the long term outcome for these patients report
poor outcome with worries about bodily sensations,
avoidance of physical activity, and reduced health-
related quality of life (HRQOL) [5-7]. McDonald et al.
[8] reported that patients had a tendency toward more
anxiety about the heart after a negative cardiac evalu-
ation than before. In another study [5], patients reported
significantly higher levels of fear about bodily symptoms
and more depression six months after a negative cardiac
evaluation compared with before the evaluation.
The perception of illness affects the way patients cope
with their complaints and is important for outcome
[9-12]. Broadbent et al. [13] showed that a four-session
intervention aiming to change illness perceptions was
associated with improved rates of return to work after a
myocardial infarction (MI). Robertsen et al. [14]
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compared illness perceptions among non-cardiac and
cardiac patients, who all were new attendees at a rapid
access chest pain clinic. Patients with non-cardiac chest
pain reported less understanding and personal control of
their chest pain both before and after the cardiac evalu-
ation than the cardiac patients. Patients with non-
cardiac chest pain or benign palpitations seem to have
similar psychological characteristics and outcomes [2,5].
However, to the best of our knowledge, no study has
evaluated illness perceptions among patients with benign
palpitations.
Illness perceptions have been assessed by The Brief Ill-
ness Perception Questionnaire (BIPQ) in several patient
groups [15]. However, there is limited knowledge about
how BIPQ item scores change following a negative car-
diac evaluation and to what extent illness perception
may explain the poor outcome in terms of significant
complaints for a high proportion of these patients.
Even though the aetiology of non-cardiac chest pain
and benign palpitations is multifactorial, psychological
treatments are useful [16,17]. Thus there is a need to
identify patients who could benefit from such treatment.
In a recent study [5] it was found that a score on the
Beck Depression Inventory (BDI) of five or above, rated
before the cardiac evaluation, served reasonably well as
a screening instrument for identifying patients in need
of psychological treatment for their complaints six
months later. An ideal screening test for use in addition
to cardiac evaluation, should be simpler than the BDI
with 21 items. Donkin et al. [18] reported that illness
perceptions as measured by the BIPQ among patients
before undergoing a normal cardiac stress test, predicted
reassurance regarding cardiac health one month later.
That study did not evaluate whether the BIPQ predicted
depression or HRQOL, or whether the test could serve
as a screening tool for identifying patients with poor
outcomes.
We aimed to evaluate the similarities and differences
in illness perceptions between patients with chest pain
and palpitations and changes in illness perceptions from
before to six months after a negative cardiac evaluation.
Other aims were to analyse the relations between illness
perceptions and depression and HRQOL before and six
months after the cardiac evaluation and to evaluate to
what extent illness perceptions before the cardiac evalu-
ation could predict outcomes six months later.
Methods
Patients
Consecutive patients referred to the cardiac outpatient
unit at the Molde Hospital in Norway between May
2006 and May 2007 for the evaluation of chest pain or
palpitations were asked to participate. The outpatient
clinic receives all referrals in a catchment area of about
75,000 inhabitants. The head of the cardiac unit
screened all referrals. The inclusion criteria were: (1) re-
ferral for a main complaint of chest pain or palpitations;
(2) age 18–65 years; and (3) ability to understand and
write Norwegian. The exclusion criteria were: (1) mental
retardation; (2) psychosis; or (3) organic heart disease
confirmed by a cardiologist. Of the 219 consecutive
patients, 21 cancelled both the cardiac and the psychi-
atric evaluations and 36 did not want to participate in
the study. A total of 162 patients participated in the psy-
chiatric and cardiac evaluations at admission. Of these,
eight were excluded, six because of coronary heart dis-
ease confirmed by the cardiac evaluation (five in the
chest pain group and one in the palpitations group), one
because of lack of Norwegian language competency, and
one because of mental retardation. No arrhythmias in
need of treatment were detected.
Furthermore, of the 154 patients who fulfilled the cri-
teria at attendance, 138 (90%) responded to mailed ques-
tionnaires at the six-month follow-up: 95/107 (89%) in
the chest pain group and 43/47 (91%) in the palpitations
group. These 138 patients were included in analyses at
attendance and at six months follow-up.
The patients who did not participate at follow-up did
not differ significantly at attendance from the partici-
pants who responded in terms of gender, age, prevalence
of psychiatric disorders, or scores for any variable at at-
tendance relevant to the outcome.
Cardiac evaluation
The patients referred for chest pain underwent a stand-
ard bicycle stress test. If the results were consistent with
or doubt arose regarding the presence of coronary heart
disease, the patients were referred for myocardial scin-
tigraphy or coronary angiography. The patients referred
for palpitations were monitored with 24-h Holter moni-
toring and seven days of electrocardiography (ECG)
monitoring (R-test) or if necessary a bicycle stress test.
The procedure is described in detail elsewhere [4].
Demographic data and psychiatric disorders
Gender, age, marital status, education, work status, dur-
ation of symptoms, numbers of days on sick leave during
the three months prior to evaluation, and any psychiatric
disorders were registered at attendance (Table 1). Psychi-
atric disorders were assessed by the Structured Clinical
Interview for DSM-IV axis I disorders (SCID-I) [19].
The first author, who is an experienced psychiatrist and
trained in the use of this instrument, performed the
interviews. For current diagnoses, the criteria had to be
met within one month before the interview. All patients
were informed about the results of the psychiatric
evaluation.
Jonsbu et al. BioPsychoSocial Medicine 2012, 6:19 Page 2 of 8
http://www.bpsmedicine.com/content/6/1/19
Brief illness perception questionnaire
The BIPQ was designed to provide a rapid assessment of
a patient’s personal perception of his or her illness [15].
BIPQ consists of eight items related to illness percep-
tion, rated on a 0–10 scale. In addition, patients are
asked to identify the three most important factors that
they believe have caused their illness. The eight aspects
of illness perceptions are: 1. consequences (“How much
does your illness affect your life?”); 2. timeline (“How
long do you think your illness will continue?”); 3. per-
sonal control (“How much control do you feel you have
over your illness?”); 4. treatment control (“How much do
you think your treatment can help your illness?”);
5. symptom frequency (“How much do you experience
symptoms from your illness?”); 6. illness concern (“How
concerned are you about your illness?”); 7. understand-
ing (“How well do you feel you understand your ill-
ness?”); and 8. emotional effect (“How much does your
illness affect you emotionally? e.g., does it make you
angry, scared, upset, or depressed?”). The questions 3, 4
and 7 are reversed, that means higher score is supposed
to be beneficial. The BIPQ shows good test–retest reli-
ability [15]. We applied an approved Norwegian transla-
tion of the BIPQ (Sivertsen and Havik 2004). In order to
adapt the questionnaire to the present non-cardiac chest
pain and benign palpitations, the word “illness” was
replaced with “complaints”. It was emphasized that
patients should relate “complaints” to the main reason
for referral (chest pain or palpitations).
Depression
The BDI [20] measures the level of depression and com-
prises 21 items rated on a 0–3 scale. The questionnaire
has sound psychometric properties, it is widely used
clinically and in research, and has also previously been
used in studies among non-cardiac chest pain and be-
nign palpitations patients [2].
Health-related quality of life (SF-36)
The 36-item SF-36 Health Survey [21] measures the
patient’s perception of HRQOL. The scores can be con-
verted into eight domains (physical functioning, physical
role limitations, bodily pain, general health perception,
vitality, social function, emotional role limitations, and
mental health) or two dimensions, the Physical Compo-
nent Scale (PCS) and the Mental Component Scale
(MCS) [22]. To limit the number of analyses, the two-
dimension approach was used in the present study.
Frequency of symptoms
The frequency of symptoms was rated as: 1, daily; 2,
weekly or more often; 3, rarely but sometimes; or 4, no
symptoms in the past six months. For patients who
reported both chest pain and palpitations, the highest
frequency score was used in the statistical analyses.
Consequences of chest pain and palpitations
The impact of chest pain or palpitations on the domains
of family, social, and work life were recorded separately
as: 1, high impact; 2, moderate impact; 3, some impact;
and 4, no impact. The highest score (the domain most
affected) among the three was used. Avoidance of phys-
ical activity was assessed by the question: “Do you avoid
physical activity because of worries about the heart?”
The response categories were: 1, often; 2, now and then;
3, rarely but sometimes; and 4, never.
Table 1 Demographic and clinical data before the cardiac evaluation
Total Chest pain Palpitations p
N= 138 n= 95 n= 43
Women 78 (56%) 47 (50%) 31 (72%) .01a
Age, mean (SD) 50 (10.7) 53 (9.4) 44 (11.0) <.001b
Married/cohabiting 107 (78%) 77 (81%) 30 (70%) ns
Vocational school/university 96 (70%) 66 (70%) 30 (70%) ns
Main source of income in the past 6 months:
Work 88 (64%) 58 (61%) 30 (70%) ns
Sickness benefit 39 (28%) 29 (31%) 10 (23%) ns
Other 11 (8%) 8 (8%) 3 (7%) ns
Duration of symptoms in months before evaluation; median (range) 9 (1–420) 9.5 (1–420) 6.5 (2–360) ns
Days on sick leave in the past 3 months; median (range) 7.5 (0–90) 8 (0–90) 2.5 (0–90) ns
Current psychiatric disorders 53 (38%) 36 (38%) 17 (40%) ns
aChi-squared test.
bStudent’s t-test.
ns, not significant.
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Clinically significant complaints
Clinically significant complaints consisted of a combin-
ation of the variables Frequency of symptoms and Con-
sequences of chest pain and palpitations. It was defined
as at least one of the following: (1) at least weekly symp-
toms; (2) at least moderate impact on family life, social
life, or work; or (3) at least avoiding physical activity
now and then because of worries about the heart. Clinic-
ally significant complaints were categorized as present
or absent, and 43% (60/138) fulfilled these criteria [5].
Procedure
The inquiry and information about participation in the
study were mailed together with the appointment time
at the cardiac outpatient clinic. The psychiatric evalu-
ation and assessments at attendance were performed be-
fore the cardiac evaluation; thus, both the interviewer
and the patients were blind to the results of the cardiac
evaluation. The questionnaires BIPQ, BDI and SF-36
were rated before and six months after the cardiac
evaluation. Data for Clinically significant complaints
were collected six months after the cardiac evaluation.
All information about the patients at the six-month fol-
low-up was collected by mail.
Ethics
The study was approved by the Regional Committee for
Medical Research Ethics and the Norwegian Social
Science Data Service. All participating patients signed an
informed consent form.
Statistical analysis
Data were compared between groups using a Chi-
squared or Fisher’s exact test for dichotomous data, the
Mann–Whitney for ordinal variables, and Student’s t-test
for continuous variables. The paired-samples t-test was
used to compare results scored before cardiac evaluation
and at follow-up. Correlations were calculated as Pear-
son’s r (for pairs of continuous variables), point-biserial
(for one dichotomous and one continuous variable), and
phi (for two dichotomous variables). To identify which
item or subset of items in BIPQ that best would predict
Clinically significant complaints, a discriminant analysis
procedure with a stepwise forward selection was run. In
addition a series of logistic regression analyses were run,
partly with forced entry of all eight items, partly with
forward (conditional) inclusion and backward (condi-
tional) elimination of independents. The best single item
identified by these procedures subsequently was tested
in combination with the remaining items (one at a time)
to investigate the predictive properties of a minimal sub-
set even further. All tests were two-tailed and p < .05
was considered significant. The Statistical Package for
Social Sciences (SPSS) software was used (version 19;
SPSS Inc., Chicago, IL, USA).
Results
BIPQ scores and changes from before to six months after
the cardiac evaluation
Before the cardiac evaluation, patients with palpitations
had a higher mean BIPQ score compared with those
with chest pain on Items 1 (consequences), 5 (symptom
frequency) and 7 (understanding). Otherwise, the groups
did not differ significantly on any item before the cardiac
evaluation or six months after (Table 2).
The BIPQ scores of the total sample are presented in
Table 3. At six-month follow-up, there were significantly
lower scores than before the cardiac evaluation for Items
1 (consequences), 4 (treatment control), 5 (symptom fre-
quency), and 6 (illness concern), while there was a sig-
nificantly higher score for Item 2 (timeline). Items 3
(personal control), 7 (understanding), and 8 (emotional
effect) did not change significantly (Table 3).
Table 2 Comparison of the chest pain group (N=95) and the palpitations group (N=43) before and six months after
negative cardiac evaluation
BIPQ (response options: 1 to 10) Before cardiac evaluation Six-month follow-up
Chest
pain
Palpitations p Chest
pain
Palpitations p
1. How much does your illness affect your life? 2.8 (2.1) 3.6 (2.5) 0.04 2.2 (2.0) 2.5 (2.0) ns
2. How long do you think your illness will continue? 3.8 (2.5) 4.4 (3.0) ns 4.8 (3.5) 4.8 (3.2) ns
3. How much control do you feel you have over your illness? 4.0 (3.0) 4.2 (2.9) ns 4.5 (3.0) 4.8 (3.1) ns
4. How much do you think your treatment can help your illness? 5.3 (2.7) 5.4 (3.0) ns 3.8 (2.9) 4.0 (3.1) ns
5. How much do you experience symptoms from your illness? 3.1 (1.9) 4.1 (2.5) 0.04 2.5 (2.1) 2.7 (1.8) ns
6. How concerned are you about your illness? 3.4 (2.1) 3.6 (2.3) ns 2.7 (2.1) 2.9 (2.4) ns
7. How well do you feel you understand your illness? 4.6 (3.0) 6.0 (2.6) 0.01 5.3 (3.0) 5.8 (3.0) ns
8. How much does your illness affect you emotionally?e.g., does it make you angry,
scared, upset, or depressed?
3.1 (2.4) 3.2 (2.6) ns 3.0 (2.4) 3.1 (2.6) ns
ns, not significant.
Mean (SD) (Student’st-test).
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Correlations between items of BIPQ and BDI and SF-36
scores before and six months after the cardiac evaluation
The correlations between scores of the BIPQ and BDI
and SF-36 before cardiac evaluation and at follow-up are
presented in Table 4. For almost all items the correla-
tions were stronger at follow-up (Table 4).
Items of the BIPQ as predictors of poor outcome
The correlation analyses for items in the BIPQ scored
before the cardiac evaluation, and Clinically significant
complaints, depression, and HRQOL six months later,
are presented in Table 5. The questions about conse-
quences (Item 1) and emotional effect (Item 8) were
most strongly correlated with Clinically significant com-
plaints six months later. A discriminant analyses with
stepwise forward inclusion of independents as well as a
series logistics regressions clearly indicated that Item 1
(asking about the consequences of the complaints) used
as a stand-alone is the best screening tool for predicting
Clinically significant complaints at follow-up. The opti-
mal cut-off for Item 1 is ≥4, yielding a sensitivity of 51%,
a specificity of 85%, a positive predictive value (PPV) of
71%, a negative predictive value (NPV) of 69%, and an
OR=6.5 (r= .38, p < .001). Combining Item 1 with one
or more of the other items of BIPQ did not improve the
scale’s predictive power significantly.
Discussion
The patients with benign palpitations reported more
symptoms (Item 5), were more affected by the symptoms
(Item1), but also had more understanding (Item 7) of
the symptoms before the cardiac evaluation compared
with the non-cardiac chest pain group, otherwise the
groups had similar illness perception scores before the
cardiac evaluation and 6 months later. Despite the
decreases in the scores for the total group regarding
consequences (Item 1), symptom frequency (Item 5),
and illness concern (Item 6), the score for emotional
Table 3 Scores on The Brief Illness Perception Questionnaire (BIPQ) measured before and six months after negative
cardiac evaluation (N=138) (Paired samples t-test)
BIPQ Before cardiac
evaluation
Mean (SD)
Six-month
follow-up
Mean (SD)
Mean
difference
p
1. How much does your illness affect your life? 3.0 (2.3) 2.3 (2.0) 0.74 <.001
2. How long do you think your illness will continue? 4.1 (2.7) 4.8 (3.4) −0.73 .01
3. How much control do you feel you have over your illness? 4.0 (3.0) 4.6 (3.0) −0.60 .07
4. How much do you think your treatment can help your illness? 5.4 (2.7) 3.8 (3.0) 1.54 <.001
5. How much do you experience symptoms from your illness? 3.4 (2.1) 2.6 (2.0) 0.83 <.001
6. How concerned are you about your illness? 3.5 (2.2) 2.8 (2.2) 0.72 <.001
7. How well do you feel you understand your illness? 5.0 (2.8) 5.4 (3.0) −0.42 .2
8. How much does your illness affect you emotionally?e.g., does it make you angry,
scared, upset, or depressed?
3.1 (2.4) 3.1 (2.5) 0.01 .9
*p < .05.
**p < .01.
Table 4 Correlations between items of The Brief Illness Perception Questionnaire (BIPQ) and outcome measures (BDI
and SF-36) rated at the same time (N=138) (Pearson’s correlation coefficient r)
Mean
(SD)
BIPQ1
consequences
BIPQ2
timeline
BIPQ3
personal
control
BIPQ4
treatment
control
BIPQ5
symptom
frequency
BIPQ6
illness
concern
BIPQ7
understanding
BIPQ8
emotional
effect
BDI-1 5.1 (5.6) .52** .23** –.05, ns .16, ns .31** .39** –.05, ns .51**
BDI-2 5.8 (6.3) .64** .28** –.31** .28** .63** .47** –.14, ns .62**
SF-36
Physical-1 65 (25) –.24** –.23** .01, ns –.22** –.20* –.16, ns .09, ns –.19*
Physical-2 69 (23) –.50** –.18* .32** –.21* –.50** –.31** .15, ns –.41**
Mental-1 73 (25) –.41** –.05, ns –.06, ns –.06, ns –.18* –.28** –.10, ns –.38**
Mental-2 74 (22) –.54** –.30** .23** –.15, ns –.51** –.47** .18* –.49**
1- before cardiac evaluation.
2- six-month follow-up.
ns, not significant.
* p < .05.
** p < .01.
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effect (Item 8) did not change significantly. The score
for understanding (Item 7) had not increased signifi-
cantly six months after the cardiac evaluation. The items
covering consequences (Item 1), symptom frequency
(Item 5), concern (Item 6), and emotional effect (Item 8)
were most strongly correlated with the BDI and SF-36
scores. These correlations were stronger at follow-up
compared with those measured before the cardiac evalu-
ation. The score of BIPQ Item 1: “How much do your
complaints affect your life?” before the cardiac evalu-
ation gave a reasonably accurate prediction of Clinically
significant complaints six months later.
The patients in the present study reported fewer
symptoms at follow-up than before the cardiac evalu-
ation (decrease in Item 5: “How much do you experience
symptoms from your illness?”). The reduction in
reported consequences (Item 1) and illness concern
(Item 6) might be a consequence of the reduction in
symptoms. The reduced faith in treatment (Item 4) and
the increase in rating of how long they thought their
complaints would continue (Item 2) might be a logical
consequence of not being offered specific treatment and
the experience of sustained complaints.
Even though the patients reported fewer symptoms
(Item 5), they were equally emotionally affected by the
illness at follow-up (Item 8). This is consistent with a
previous report from the same sample describing an in-
crease in fear of bodily sensations and depression from
before the cardiac evaluation to six-month follow-up [5],
and with a study by McDonald et al. [8] noting that
patients worry more about their heart after than before a
normal cardiac evaluation. Furthermore, the patients in
the present study did not report significantly more
understanding (Item 7) or control (Item 3) of the illness
even though all of them had been through a cardiac
evaluation and during this process had spoken to a car-
diologist (all chest pain patients) or to a specialized car-
diac care nurse (all patients with palpitations). This is in
line with the results of the study by Robertsen et al. who
investigated this issue before cardiac evaluation and at
two-week and two-month follow-up for patients with
non-cardiac chest pain [14]. These findings are thought-
provoking and point to the need for more focus and
research on the consequences of a normal cardiac
evaluation. It should lead to more specific information
about non-cardiac conditions to increase the sense of
security for these patients.
Items about how much the illness affected patients’
life (Item 1), how often they experienced symptoms
(Item 5), how concerned they were about the illness
(Item 6), and how much they were emotionally affected
by the illness (Item 8) were most strongly correlated
with depression and HRQOL. Surprisingly, the correla-
tions between items of BIPQ and depression and the
HRQOL were substantially stronger at follow-up. This
finding indicates that, during the evaluation for cardiac
disorders, these patients are getting more focused on
their symptoms, and that the interpretation of the
symptoms appear to be more closely linked to how they
evaluate their well being after the cardiac evaluation.
This might be an unintended effect of normal cardiac
evaluation and might contribute to the tendency to-
wards poor outcomes among these patients. Strategies
to avoid such developments among patients should be
highlighted.
The items about consequences (Item 1), symptom fre-
quency (Item 5), illness concern (Item 6), and emo-
tional effect (Item 8) were most strongly correlated
with depression and HRQOL six months later. In the
study by Donkin et al. [18], the same items of BIPQ
were the strongest predictors of low reassurance one
month after a negative exercise stress test. Because
most of the models that aim to explain the develop-
ment of medically unexplained symptoms emphasize
frightening misinterpretations as a main reason [23],
this match of items, which predicted reassurance and
Table 5 Correlations between items of The Brief Illness Perception Questionnaire (BIPQ) rated before the cardiac
evaluation and Clinically significant complaints (0 = no, 1 = yes), BDI, and SF-36 rated six-month follow-up (N=138)
(Pearson’s correlation coefficient r and point-biserial)
BIPQ1
consequences
BIPQ2
timeline
BIPQ3
personal
control
BIPQ4
treatment
control
BIPQ5
symptom
frequency
BIPQ6
illness
concern
BIPQ7
understanding
BIPQ8
emotional
effect
Clinically
significant
complaints
.41** .22* –.10, ns .10, ns .34** .33** –.01, ns .28**
BDI .45** .25** –.08, ns .18* .30** .38** –.05, ns .47**
SF-36
Physical –.28** –.17* .12, ns –.06, ns –.23** –.15, ns .02, ns –.27**
Mental –.46** –.26** .09, ns –.12, ns –.35** –.34** –.02, ns –.43**
ns, not significant.
*p < .05.
**p < .01.
Jonsbu et al. BioPsychoSocial Medicine 2012, 6:19 Page 6 of 8
http://www.bpsmedicine.com/content/6/1/19
health (Clinically significant complaints, depression and
HRQOL), is as expected.
The question about consequences (Item 1), with a cut-
off point at ≥4, had rather good properties in screening
for Clinically significant complaints six months later.
Compared with the 21-item BDI (with a set point at ≥5)
used in the same sample with the same dependent vari-
able (Clinically significant complaints) [5], the PPV, spe-
cificity, and OR values were better for the one-item
questionnaire (71% vs 66%, 85% vs 74%, 5.7 vs 5.2, re-
spectively) but the sensitivity and NPV were lower (51%
vs 64% and 69% vs 73%, respectively). Such a one-
question screening instrument is easier to implement in
a cardiac setting than the 21-item BDI. Therefore, we
recommend the use of Item 1 in the BIPQ as a simple
screening instrument during cardiac evaluation.
Non-cardiac chest pain and benign palpitations differ
from most physical disorders by the unexplained nature
of the symptoms and the lack of treatment. Items 3 (per-
sonal control), 4 (treatment control) and 7 (understand-
ing) will perhaps be only vaguely understood by the
patients as relating to these conditions. Our study sup-
ports this assumption by revealing weaker correlation
with other health assessments both before and after the
cardiac evaluation (Table 4) and lack of significant pre-
diction of outcome for these items (Table 5). Items 1
(consequences), 5 (symptom frequency), 6 (illness con-
cern) and 8 (emotional effect) showed strong correla-
tions with other health assessments and rather good
prediction of outcome. We suppose this might be the
case for other medically unexplained symptoms as well,
and this information should be emphasized when these
patients are received in the health care system. Treat-
ment should emphasize on increasing personal control
and understanding in an attempt to help patients to han-
dle their complaints in a better way. Illness perceptions
seem to be valuable in the understanding of the mechan-
isms behind poor outcome for these patients and also
valuable when focus for treatment is decided upon.
Strengths and limitations
A major strength of this study is that it was performed
in a general cardiac setting and included consecutive
patients in a known catchment area. As for limitations,
the assessment of Clinically significant complaints at
follow-up was obtained by questionnaires developed for
the present study and have not been tested independ-
ently for psychometric properties. There were some
dropouts (10%) at follow-up. We speculate that patients,
who were worried about their health and/or experienced
sustained complaints, were more interested in participat-
ing in the follow-up investigation, and this might have led
to a systematic loss of subjects. Internal consistency be-
tween variables tends to get stronger when questionnaires
are repeatedly administered to the same respondents
(learning effect), thus probably contributing to some of
the observed increases over time in most correlations.
Conclusions
Patients with non-cardiac chest pain and patients with
benign palpitations had almost similar perception of
their symptoms. BIPQ consisting of eight different items
regarding illness perception, contributed to clarify the
mechanisms behind poor outcomes. The BIPQ item
“How much does your illness affect your life” showed
reasonably good properties to predict outcomes six
months later.
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